Serum ST6GAL1 is a novel biomarker for predicting efficacy of tyrosine kinase inhibitors in hepatocellular carcinoma by detecting FGF19 expressing tumor
Serum ST6GAL1 is a novel biomarker for predicting efficacy of tyrosine kinase inhibitors in hepatocellular carcinoma by detecting FGF19 expressing tumor
复制标题
血清 ST6GAL1 是一种新型生物标志物，通过检测表达 FGF19 的肿瘤来预测酪氨酸激酶抑制剂在肝细胞癌中的疗效
DOI：
--
复制
发表时间：
2021
期刊：
影响因子：
--
通讯作者：
Tetsuo Takehara
中科院分区：
文献类型：
--
作者：
Yuta Myojin;Takahiro Kodama;Hayato Hikita;Ryotaro Sakamori;Tomohide Tatsumi;Tetsuo Takehara
